News
SalvaRx Group plc - Result of AGM
RNS Number: 6090 M SalvaRx Group plc 31 July 2017. SalvaRx, the drug discovery and development company focused on cancer immunotherapy, is pleased to announce that at its Annual General Meeting, which was held earlier today, all resolutions were duly passed.. For more information on SalvaRx please visit: www.salvarx.io.
RNS Number: 6090 M SalvaRx Group plc 31 July 2017. SalvaRx, the drug discovery and development company focused on cancer immunotherapy, is pleased to announce that at its Annual General Meeting, which was held earlier today, all resolutions were duly passed.. For more information on SalvaRx please visit: www.salvarx.io.